Ventricular Tachycardia

Clinical Trial Finder

Many patients with ventricular tachycardia are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction

Condition:   Ventricular Tachycardia
Intervention:   Procedure: VT ablation
Sponsor:   Biotronik SE & Co. KG
Recruiting - verified September 2015

Complex Pathophysiological Background of Heart Failure Deterioration

Condition:   Heart Failure
Sponsor:   Military Institute of Medicine, Poland
Recruiting - verified October 2015

Utility of ICD Electrograms During Ventricular Tachycardia Ablation

Condition:   Sustained Monomorphic Ventricular Tachycardia
Interventions:   Procedure: Conventional RF catheter ablation;   Procedure: Investigational RF Catheter Ablation using ICD-EG information
Sponsor:   Fundación Hospital de Madrid
Recruiting - verified September 2015

Botulinum Toxin Injection to Prevent Ventricular Arrhythmias

Conditions:   Symptomatic Ventricular Asystolia;   Ventricular Tachycardia
Intervention:   Drug: Botulinum Toxin
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified September 2015

To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients

Conditions:   Cardiac Event;   Sudden Cardiac Death;   Death;   Ventricular Fibrillation;   Ventricular Tachycardia
Interventions:   Device: Upstroke Compression Defibrillation;   Device: Precompression Defibrillation
Sponsors:   Singapore General Hospital;   Zoll Medical Corporation
Not yet recruiting - verified September 2015

Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)

Condition:   Contraception
Interventions:   Drug: Moxifloxacin;   Drug: NOMAC-E2 (Org 10486-0 + Org 2317);   Drug: Moxifloxacin placebo;   Drug: NOMAC-E2 placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified September 2015

Get CardioSmart

You're Invited